Aptamer-functionalized nucleic acid nanotechnology for biosensing, bioimaging and cancer therapy

Xiaofang Zheng(Chinese Academy of Sciences), Ruizi Peng(Hunan University), Qiang Zhang(Hunan University), Minghui Song(Chinese Academy of Sciences), Guoli Li(Nanjing General Hospital of Nanjing Military Command), Zhiyong Huang(Beijing Institute of Technology)

Nanoscale

November 12, 2024

10.1039/d4nr04360j

Cited by 18

Related Papers

Characterization of ferroptosis in murine models of hemochromatosis

|Hepatology|2017|669

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

|The Lancet Oncology|2021|436

Genome sequencing and comparison of two nonhuman primate animal models, the cynomolgus and Chinese rhesus macaques

|Nature Biotechnology|2011|321

Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-α/SREBP1 pathway and modulating the gut microbiota in ApoE-/- mice fed with HFD

|Journal of Ethnopharmacology|2020|87

Leveraging Aptamer-Based DNA Nanotechnology for Bioanalysis and Cancer Therapeutics

|Accounts of Materials Research|2024|87